Rwanda to begin trials for Marburg Virus vaccine and treatment

Following the confirmation of Marburg virus cases in Rwanda, where 36 people have been infected since September 27, 2024, and 11 have succumbed to the disease, the Ministry of Health has announced plans to start trials for a vaccine and treatment to combat the virus.

Dr. Yvan Butera, the State Minister in the Ministry of Health, revealed that the trials would prioritize those most at risk of contracting the virus, particularly healthcare workers and individuals in close contact with infected patients.

"We are about to begin trials for both vaccination and treatment to protect those at high risk of contracting the virus," said Dr. Butera.

The Marburg virus, which spreads through contact with bodily fluids from an infected person, has claimed 11 lives in Rwanda, with the latest death reported on October 2, 2024. Of the 36 confirmed cases, 25 patients remain under medical care, while over 410 people who have been in contact with the infected are under surveillance.

Health Minister Dr. Sabin Nsanzimana stated that vaccinations could begin within the next two weeks, starting with patients already admitted to hospitals.

"We are planning to roll out the vaccination very soon, but we are still finalizing the exact dates. The vaccines are in the final stages of research, and there are also new treatments being developed specifically for this virus, though not yet available on the market. These efforts are being expedited with support from the World Health Organization (WHO)," said Dr. Nsanzimana.

The trial will involve vaccines and treatments that are in the final phase of clinical trials, which are being conducted in collaboration with WHO. Rwanda is working closely with WHO to ensure the swift implementation of these solutions.

The symptoms of the Marburg virus include high fever, severe headaches, vomiting, and diarrhea, which resemble those of other diseases such as malaria and typhoid.

Dr. Nsanzimana also noted that research is still ongoing to identify the origin of the virus in Rwanda.

Meanwhile, Rwanda continues to strengthen measures to prevent further spread of the virus, urging the public to adhere strictly to health guidelines, particularly in situations where contact with infected individuals is possible.